| ²é¿´: 1802 | »Ø¸´: 1 | |||
country198519ľ³æ (СÓÐÃûÆø)
|
[½»Á÷]
¡¾ÇóÖú¡¿ÒÁÂíÌæÄá¼×»ÇËáÑÎ Ë®ÈÜÐÔÎÊÌâ ÒÑÓÐ1È˲ÎÓë
|
| ÒòÎªÖÆ¼Á·½ÃæÐèÒª£¬ÇóÖúÒÁÂíÌæÄá¼×»ÇËáÑÎ µÄË®ÈÜÐÔÊý¾Ý£¬¶ÔË®Èܽâ¶ÈÊǶàÉÙ£¿ |
» ²ÂÄãϲ»¶
±ûͪËἤøµÄÒÖÖÆ¼ÁºÍ¼¤¶¯¼Á
ÒѾÓÐ1È˻ظ´
Ò»Ö¾Ô¸¹ãÒ½ ҩѧר˶ ×Ü·Ö383 ÒѹýËļ¶ Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ89È˻ظ´
ÇëÎÊÔõô²ÅÄÜÔÚÓÐôÈ»ù´æÔÚµÄÇé¿öÏ£¬Ö»¸ø·ÓôÇ»ùÉϼ׻ù
ÒѾÓÐ4È˻ظ´
²Î±ÈÖÆ¼Á£¬×Ô¼º×öµÄPKÊý¾ÝÓëIF×ÊÁϱ¨µÀµÄÊý¾ÝÏà²îºÜ´ó
ÒѾÓÐ2È˻ظ´
ÆíÇóÖб¾×Ó
ÒѾÓÐ0È˻ظ´
¸÷λ´óÀУ¬H¿ÚÃæÉÏʲôʱºò»áÆÀ£¿£¿£¿
ÒѾÓÐ30È˻ظ´
2026Äêɽ¶«´óѧº£ÑóѧԺÉúÎïÓëÒ½Ò©²©Ê¿ÕÐÉú-Àîϼ¿ÎÌâ×é
ÒѾÓÐ0È˻ظ´
²©Ê¿Ñо¿ÉúÕÐÉú
ÒѾÓÐ0È˻ظ´
Ò©Àíѧ¡¢ÁÙ´²Ò©Ñ§·½Ïò µ÷¼Á
ÒѾÓÐ1È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÈýÒÒ°·ÑÎËáÑεĺó´¦Àí
ÒѾÓÐ27È˻ظ´
Ò»ÖÖ»¯ºÏÎïµÄÈܽâÎÊÌ⠷ѽâ ÖØ½ðÇóÖú
ÒѾÓÐ6È˻ظ´
Çë½Ìõ¥Ë®½âµÄÎÊÌâ
ÒѾÓÐ3È˻ظ´
¿¹¾úëÄÍÑÑκóͻȻûÓÐÒÖ¾ú»îÐÔÁË ÇóÖú
ÒѾÓÐ14È˻ظ´
origin 8 Èýά»Í¼ÎÊÌâ
ÒѾÓÐ13È˻ظ´
²Î¿¼ÎÄÏ×À´×ÔÁ½¸öEndnoteÊý¾Ý¿â£¬¸üÐÂÊÇ·ñ»á³öÎÊÌ⣿
ÒѾÓÐ6È˻ظ´
¹ØÓÚ¾Û°±õ¥Ô¤ÒÒËáÒÒõ¥µÈÈܼÁµÄÏàÈÜÎÊÌâ¡£¡£¡£¡£
ÒѾÓÐ5È˻ظ´
ÇóÖú¼×»ÇËáÒÁÂíÌæÄáÓйØÎïÖʺͺ¬Á¿²â¶¨·ÖÎö·½·¨
ÒѾÓÐ7È˻ظ´
¡¾½»Á÷¡¿¼×»ÇËáÒÁÂíÌæÄáÔÁÏÒ©ÔÓÖÊÎÊÌâ
ÒѾÓÐ13È˻ظ´
¡¾ÌÖÂÛ¡¿ÒÁÂíÌæÄáºÍ¼ª·ÇÌæÄữºÏÎïרÀû
ÒѾÓÐ8È˻ظ´
¡¾ÌÖÂÛ¡¿¼×»ÇËáÒÁÂíÌæÄáµÄ¸±×÷ÓÃ
ÒѾÓÐ14È˻ظ´
¡¾ÇóÖú¡¿¼×»ÇËáÒÁÂíÌæÄá ÖÊÁ¿±ê×¼
ÒѾÓÐ20È˻ظ´
¼×»ÇËáÒÁÂíÌæÄáÖм׻ÇËáÈçºÎ¼ø±ð
ÒѾÓÐ2È˻ظ´

ÍÃ×Ó²»¹Ô
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1296.3
- É¢½ð: 320
- ºì»¨: 4
- Ìû×Ó: 413
- ÔÚÏß: 82Сʱ
- ³æºÅ: 12895
- ×¢²á: 2003-05-29
- ÐÔ±ð: GG
- רҵ: Ò©Îï·ÖÎö
|
CAS Registry Number: 220127-57-1 Manufacturers' Codes: STI-571; CGP-57148B Trademarks: Gleevec (Novartis); Glivec (Novartis) Molecular Formula: C29H31N7O.CH3SO3H Molecular Weight: 589.71 Percent Composition: C 61.10%, H 5.98%, N 16.63%, O 10.85%, S 5.44% Literature References: Prepn of crystalline form: J. Zimmermann et al., WO 9903854 (1999 to Novartis). Properties: Occurs in 2 crystalline modifications. a-form, begins to melt at 226¡ã; b-form, mp 217¡ã. Lipophilic at pH 7.4. Soly in water: >100 g/l (pH 4.2); 49 mg/l (pH 7.4). |
2Â¥2010-08-06 16:41:30














»Ø¸´´ËÂ¥